These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 9093725)

  • 1. Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer.
    Glimelius B; Ekström K; Hoffman K; Graf W; Sjödén PO; Haglund U; Svensson C; Enander LK; Linné T; Sellström H; Heuman R
    Ann Oncol; 1997 Feb; 8(2):163-8. PubMed ID: 9093725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer.
    Glimelius B; Hoffman K; Sjödén PO; Jacobsson G; Sellström H; Enander LK; Linné T; Svensson C
    Ann Oncol; 1996 Aug; 7(6):593-600. PubMed ID: 8879373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: A trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group.
    Vanhoefer U; Rougier P; Wilke H; Ducreux MP; Lacave AJ; Van Cutsem E; Planker M; Santos JG; Piedbois P; Paillot B; Bodenstein H; Schmoll HJ; Bleiberg H; Nordlinger B; Couvreur ML; Baron B; Wils JA
    J Clin Oncol; 2000 Jul; 18(14):2648-57. PubMed ID: 10894863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Etoposide, leucovorin and 5-fluorouracil in advanced gastric cancer: a phase II study.
    Van Cutsem E; Filez L; Dewyspelaere J; Penninckx F; Janssens J
    Anticancer Res; 1995; 15(3):1079-80. PubMed ID: 7645929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy in gastric cancer: an economic evaluation of the FAM (5-fluorouracil, adriamycin, mitomycin C) versus ELF (etoposide, leucovorin, 5-fluorouracil) regimens.
    Norum J; Angelsen V
    J Chemother; 1995 Oct; 7(5):455-9. PubMed ID: 8596132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II study of the modified regimen of etoposide, leucovorin and 5-fluorouracil for patients with advanced gastric cancer.
    Chiou TJ; Tung SL; Hsieh RK; Wang WS; Yen CC; Fan FS; Liu JH; Chen PM
    Jpn J Clin Oncol; 1998 May; 28(5):318-22. PubMed ID: 9703859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of advanced gastric cancer with oral etoposide, leucovorin and tegafur: experience with an oral modification of the etoposide, leucovorin and 5-fluorouracil (ELF) regimen.
    Raderer M; Kornek GV; Hejna MH; Miholic J; Weinlaender G; Brodowicz T; Fiebiger WC; Valencak JB; Scheithauer W
    Eur J Cancer; 1998 Jun; 34(7):1128-30. PubMed ID: 9849466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of palliative chemotherapy in advanced gastrointestinal cancer.
    Glimelius B; Hoffman K; Graf W; Haglund U; Nyrén O; Påhlman L; Sjödén PO
    Ann Oncol; 1995 Mar; 6(3):267-74. PubMed ID: 7542021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etoposide, l-leucovorin and fluorouracil (ELF) regimen in metastatic gastric cancer: a phase II study.
    Adamo V; Scimone A; Maisano R; Altavilla G; Ferraro G; Laudani A; Pergolizzi S; Zanghì M
    J Chemother; 1999 Feb; 11(1):74-7. PubMed ID: 10078785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New developments in the treatment of gastric carcinoma.
    Wilke H; Preusser P; Fink U; Achterrath W; Meyer HJ; Stahl M; Lenaz L; Meyer J; Siewert JR; Geerlings H
    Semin Oncol; 1990 Feb; 17(1 Suppl 2):61-70. PubMed ID: 2305269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic overview of chemotherapy effects in colorectal cancer.
    Ragnhammar P; Hafström L; Nygren P; Glimelius B;
    Acta Oncol; 2001; 40(2-3):282-308. PubMed ID: 11441937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination chemotherapy with granulocyte-macrophage-colony stimulating factor in patients with locoregional and metastatic gastric adenocarcinoma.
    Partyka S; Dumas P; Ajani J
    Cancer; 1999 Jun; 85(11):2336-9. PubMed ID: 10357402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of advanced gastric cancer with a modified regimen of etoposide/leucovorin/5-fluorouracil.
    Chiou TJ; Kung SP; Hsieh RK; Fan S; Tzeng CH; Wei CH; Chen PM
    Cancer Invest; 1996; 14(3):197-201. PubMed ID: 8630679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cisplatin, etoposide, and weekly high-dose 5-fluorouracil and leucovorin infusion (PE-HDFL)--a very effective regimen with good patients' compliance for advanced gastric cancer.
    Cheng AL; Yeh KH; Lin JT; Hsu C; Liu MY
    Anticancer Res; 1998; 18(2B):1267-72. PubMed ID: 9615799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study of the etoposide, leucovorin and fluorouracil combination for patients with advanced gastric cancer unsuitable for aggressive chemotherapy.
    di Bartolomeo M; Bajetta E; de Braud F; Bochicchio AM; Gebbia V; Bozzetti F; Doci R; Bonfanti G; Cozzaglio L
    Oncology; 1995; 52(1):41-4. PubMed ID: 7800341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination 5-fluoruracil/cisplatinum versus 5-fluoruracil/leucovorin adjuvant chemotherapy efficacy for R0 gastric resection in locally invasive gastric cancer.
    Yamada S; Ritchim P; Charkrabandhu T; Jongraksat W
    J Med Assoc Thai; 2012 Dec; 95(12):1517-23. PubMed ID: 23390781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer.
    Scheithauer W; Rosen H; Kornek GV; Sebesta C; Depisch D
    BMJ; 1993 Mar; 306(6880):752-5. PubMed ID: 7683942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective, randomized, multicenter, phase III study of fluorouracil, leucovorin, and irinotecan versus epirubicin, cisplatin, and capecitabine in advanced gastric adenocarcinoma: a French intergroup (Fédération Francophone de Cancérologie Digestive, Fédération Nationale des Centres de Lutte Contre le Cancer, and Groupe Coopérateur Multidisciplinaire en Oncologie) study.
    Guimbaud R; Louvet C; Ries P; Ychou M; Maillard E; André T; Gornet JM; Aparicio T; Nguyen S; Azzedine A; Etienne PL; Boucher E; Rebischung C; Hammel P; Rougier P; Bedenne L; Bouché O
    J Clin Oncol; 2014 Nov; 32(31):3520-6. PubMed ID: 25287828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life with docetaxel plus cisplatin and fluorouracil compared with cisplatin and fluorouracil from a phase III trial for advanced gastric or gastroesophageal adenocarcinoma: the V-325 Study Group.
    Ajani JA; Moiseyenko VM; Tjulandin S; Majlis A; Constenla M; Boni C; Rodrigues A; Fodor M; Chao Y; Voznyi E; Awad L; Van Cutsem E;
    J Clin Oncol; 2007 Aug; 25(22):3210-6. PubMed ID: 17664468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study).
    De Vita F; Giuliani F; Orditura M; Maiello E; Galizia G; Di Martino N; Montemurro F; Cartenì G; Manzione L; Romito S; Gebbia V; Ciardiello F; Catalano G; Colucci G;
    Ann Oncol; 2007 Aug; 18(8):1354-8. PubMed ID: 17525087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.